Author

Nellie Ratsamee

Institution: Fred Hutch Cancer Center

Observed institution: Fred Hutch Cancer Center

OpenAlex ID: A5116432322

Pre-Hematopoietic Cell Transplantation Ruxolitinib in Transplantation-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective Study

2025 · Rachel B. Salit, Xinyi Fan, et al. · Transplantation and Cellular Therapy · 2

Phase II Single Center Prospective Study of Ruxolitinib in Addition to Standard Graft Versus Host Disease Prophylaxis in Patients with Myelofibrosis Demonstrates Encouraging Outcomes.

2025 · Rachel B. Salit, Kevin Ng, et al. · Transplantation and Cellular Therapy · 1

Phase II Prospective Study of Intentional Pre-Treatment of Hematopoietic Cell Transplant Eligible Myelofibrosis Patients with Ruxolitinib

2025 · Rachel B. Salit, Xinyi Fan, et al. · Transplantation and Cellular Therapy

Works count: 3

Citation count: 3

H-index: 1

I10-index: